Amicus Therapeutics ApS Financials, key figures and credit report
Gross profit 1 441.1 kDKK FY 2025 -27.5% vs 2024
EBIT 84.0 kDKK FY 2025 -22.2% vs 2024
Net debt - 376.9 kDKK FY 2025 -4.9% vs 2024
Quick ratio 1.1 FY 2025 +0 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 644.17 | 1 575.51 | 1 732.21 | 1 987.09 | 1 441.14 |
| Employee benefit expenses | - 607.47 | -1 491.97 | -1 635.91 | -1 879.10 | -1 357.17 |
| EBIT | 36.70 | 83.54 | 96.31 | 107.99 | 83.97 |
| Other financial income | 91.29 | ||||
| Other financial expenses | -11.89 | -14.31 | -29.15 | -86.72 | -5.30 |
| Pre-tax profit | 24.81 | 69.23 | 67.16 | 21.27 | 169.96 |
| Income taxes | -5.46 | -15.19 | -14.94 | -4.80 | -54.95 |
| Net earnings | 19.35 | 54.03 | 52.22 | 16.48 | 115.00 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 18.20 | 11.05 | |||
| Current amounts owed by group member comp. | 164.71 | 278.73 | 637.79 | 174.53 | |
| Current other receivables | 31.07 | 59.48 | 46.94 | 61.85 | 98.16 |
| Current deferred tax assets | 6.05 | ||||
| Short term receivables total | 220.03 | 349.26 | 684.73 | 61.85 | 272.70 |
| Cash and bank deposits | 2 195.82 | 268.05 | 49.32 | 3 364.33 | 3 957.84 |
| Cash and cash equivalents | 2 195.82 | 268.05 | 49.32 | 3 364.33 | 3 957.84 |
| Balance sheet total (assets) | 2 415.85 | 617.32 | 734.06 | 3 426.18 | 4 230.54 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | 179.71 | 199.06 | 253.09 | 243.16 | 259.64 |
| Profit of the financial year | 19.35 | 54.03 | 52.22 | 16.48 | 115.00 |
| Shareholders equity total | 249.06 | 303.09 | 355.31 | 309.64 | 424.64 |
| Non-current liabilities total | |||||
| Current trade creditors | 152.04 | 149.74 | 93.06 | 47.15 | 45.36 |
| Current owed to group member | 1 979.20 | 3 004.98 | 3 580.94 | ||
| Short-term deferred tax liabilities | 7.31 | 8.94 | 3.33 | 51.04 | |
| Other non-interest bearing current liabilities | 35.55 | 157.17 | 276.74 | 61.08 | 128.55 |
| Current liabilities total | 2 166.79 | 314.23 | 378.74 | 3 116.54 | 3 805.90 |
| Balance sheet total (liabilities) | 2 415.85 | 617.32 | 734.06 | 3 426.18 | 4 230.54 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated